The Fibroblast Growth Factor 23: A New Player in the Field of Cardiovascular, Bone and Renal Disease

Publisher： Bentham Science Publishers

E-ISSN： 1875-6212|8|3|404-411

ISSN： 1570-1611

Source： Current Vascular Pharmacology, Vol.8, Iss.3, 2010-05, pp. : 404-411

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Circulating Fibroblast Growth Factor 23 Increases Following Intermittent Parathyroid Hormone (1–34) in Postmenopausal Osteoporosis: Association with Biomarker of Bone Formation

By Mahon James  

Calcified Tissue International, Vol. 88, Iss. 6, 2011-06 ,pp. : 530-530

Springer Publishing Company

Access to resources Recommend Favorite

Circulating Fibroblast Growth Factor-23 Increases Following Intermittent Parathyroid Hormone (1–34) in Postmenopausal Osteoporosis: Association with Biomarker of Bone Formation

By Hampson Geeta  

Calcified Tissue International, Vol. 88, Iss. 6, 2011-06 ,pp. : 531-531

Springer Publishing Company

Access to resources Recommend Favorite

Circulating Fibroblast Growth Factor-23 Increases Following Intermittent Parathyroid Hormone (1–34) in Postmenopausal Osteoporosis: Association with Biomarker of Bone Formation

By Sridharan M.   Cheung J.   Moore A.   Frost M.   Fraser W.   Fogelman I.   Hampson G.  

Calcified Tissue International, Vol. 87, Iss. 5, 2010-11 ,pp. : 398-405

Springer Publishing Company

Access to resources Recommend Favorite

New insights in the biology of fibroblast growth factor-2

By Bikfalvi Andreas   Savona Catherine   Perollet Catherine   Javerzat Sophie  

Angiogenesis, Vol. 1, Iss. 2, 1998-01 ,pp. : 155-173

Springer Publishing Company

Access to resources Recommend Favorite

Fibroblast Growth Factor, A Review

By Chibesakunda Grace  

Kidney, Vol. 19, Iss. 6, 2010-12 ,pp. : 290-293

Springer Publishing Company

Access to resources Recommend Favorite